196 related articles for article (PubMed ID: 9728551)
1. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor.
Draper D; Donohoe W; Mortimer L; Heine RP
J Infect Dis; 1998 Sep; 178(3):815-9. PubMed ID: 9728551
[TBL] [Abstract][Full Text] [Related]
2. Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.
Huppert JS; Huang B; Chen C; Dawood HY; Fichorova RN
J Infect Dis; 2013 May; 207(9):1462-70. PubMed ID: 23355743
[TBL] [Abstract][Full Text] [Related]
3. Trichocystatin-2 (TC-2): an endogenous inhibitor of cysteine proteinases in Trichomonas vaginalis is associated with TvCP39.
Puente-Rivera J; Ramón-Luing Lde L; Figueroa-Angulo EE; Ortega-López J; Arroyo R
Int J Biochem Cell Biol; 2014 Sep; 54():255-65. PubMed ID: 25200185
[TBL] [Abstract][Full Text] [Related]
4. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.
Wahl SM; McNeely TB; Janoff EN; Shugars D; Worley P; Tucker C; Orenstein JM
Oral Dis; 1997 May; 3 Suppl 1():S64-9. PubMed ID: 9456660
[TBL] [Abstract][Full Text] [Related]
5. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.
Baqui AA; Meiller TF; Falkler WA
Clin Diagn Lab Immunol; 1999 Nov; 6(6):808-11. PubMed ID: 10548568
[TBL] [Abstract][Full Text] [Related]
6. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
Rao NV; Marshall BC; Gray BH; Hoidal JR
Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
Skott P; Lucht E; Ehnlund M; Björling E
Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
[TBL] [Abstract][Full Text] [Related]
8. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
9. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM
J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor.
Turpin JA; Schaeffer CA; Bu M; Graham L; Buckheit RW; Clanton D; Rice WG
Antiviral Res; 1996 Mar; 29(2-3):269-77. PubMed ID: 8739605
[TBL] [Abstract][Full Text] [Related]
11. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk.
Farquhar C; VanCott TC; Mbori-Ngacha DA; Horani L; Bosire RK; Kreiss JK; Richardson BA; John-Stewart GC
J Infect Dis; 2002 Oct; 186(8):1173-6. PubMed ID: 12355371
[TBL] [Abstract][Full Text] [Related]
12. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN
Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984
[TBL] [Abstract][Full Text] [Related]
13. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
[TBL] [Abstract][Full Text] [Related]
14. Uterine-associated serine protease inhibitors stimulate deoxyribonucleic acid synthesis in porcine endometrial glandular epithelial cells of pregnancy.
Badinga L; Michel FJ; Simmen RC
Biol Reprod; 1999 Aug; 61(2):380-7. PubMed ID: 10411515
[TBL] [Abstract][Full Text] [Related]
15. Polyamine depletion down-regulates expression of the Trichomonas vaginalis cytotoxic CP65, a 65-kDa cysteine proteinase involved in cellular damage.
Alvarez-Sánchez ME; Carvajal-Gamez BI; Solano-González E; Martínez-Benitez M; Garcia AF; Alderete JF; Arroyo R
Int J Biochem Cell Biol; 2008; 40(11):2442-51. PubMed ID: 18586550
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
17. The elimination of secretory leukocyte protease inhibitor (SLPI) from the gastrointestinal tract in man.
Nyström M; Bergenfeldt M; Ohlsson K
Scand J Clin Lab Invest; 1997 Apr; 57(2):119-25. PubMed ID: 9200270
[TBL] [Abstract][Full Text] [Related]
18. Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma.
Fath MA; Wu X; Hileman RE; Linhardt RJ; Kashem MA; Nelson RM; Wright CD; Abraham WM
J Biol Chem; 1998 May; 273(22):13563-9. PubMed ID: 9593692
[TBL] [Abstract][Full Text] [Related]
19. Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.
Taggart CC; Greene CM; McElvaney NG; O'Neill S
J Biol Chem; 2002 Sep; 277(37):33648-53. PubMed ID: 12084717
[TBL] [Abstract][Full Text] [Related]
20. Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa.
Bergenfeldt M; Nyström M; Bohe M; Lindström C; Polling A; Ohlsson K
J Gastroenterol; 1996 Feb; 31(1):18-23. PubMed ID: 8808424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
